Ask AI
ProCE Banner Activity

Tardive Dyskinesia in Long-Term Care: Nuances in Detection and Management

Clinical Thought

Read this expert commentary to learn how to improve diagnosis and management of tardive dyskinesia in older patients in long-term care settings, including optimal use of available pharmacologic agents.

Released: April 25, 2024

Expiration: April 24, 2025

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Teva Pharmaceuticals.

Teva Pharmaceuticals

Faculty Disclosure

Primary Author

Sanjay Gupta, MD

CMO BryLin Hospital
Volunteer Professor of Psychiatry
Jacob's School of Medicine
SUNY Upstate Medical University
Chief Division of Psychiatry, Roswell Park Cancer Center
Medical Director, Endeavor Health Services
Buffalo, New York

Sanjay Gupta, MD: consultant/advisor/speaker: AbbVie, Alkermes, Bristol Myers Squibb, Intracellular Therapies, Johnson & Johnson, Neurocrine, Otsuka, Teva, Vanda.